EP Patent

EP2732824A1 — Compositions and methods for increasing reproduction performance in non human mammals using alpha-beta-linked follicle stimulating hormone

Assigned to Ceva Sante Animale SA · Expires 2014-05-21 · 12y expired

What this patent protects

The present invention relates to methods and compositions for increasing reproduction performance in non-human mammals using a biologically active recombinant Follicle Stimulating Hormone (rFSH). The invention also relates to methods for increasing ovulation or embryo production …

USPTO Abstract

The present invention relates to methods and compositions for increasing reproduction performance in non-human mammals using a biologically active recombinant Follicle Stimulating Hormone (rFSH). The invention also relates to methods for increasing ovulation or embryo production or pregnancies in non-human mammal using rFSH. The invention may be used in particular in ungulates such as bovine or equine.

Drugs covered by this patent

Patent Metadata

Patent number
EP2732824A1
Jurisdiction
EP
Classification
—
Expires
2014-05-21
Drug substance claim
No
Drug product claim
No
Assignee
Ceva Sante Animale SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.